RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$8.94
+0.33 (+3.83%)
Open$8.96
Previous Close$8.61
Day High$9.44
Day Low$8.90
52W High$22.03
52W Low$6.08
Volume—
Avg Volume8.4K
Market Cap7.83M
P/E Ratio—
EPS$-352.74
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+121.7% upside
Current
$8.94
$8.94
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.00M | 1.95M | 1.64M |
| Net Income | -582,985 | -504,236 | -420,334 |
| Profit Margin | -29.1% | -25.9% | -25.6% |
| EBITDA | -690,102 | -649,673 | -530,744 |
| Free Cash Flow | -724,048 | -502,155 | -609,665 |
| Rev Growth | -0.1% | -1.2% | +14.7% |
| Debt/Equity | 1.05 | 0.94 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |